Viewing Study NCT05432635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:36 PM
Ignite Modification Date: 2026-05-16 @ 4:57 PM
Study NCT ID: NCT05432635
Status: RECRUITING
Last Update Posted: 2025-02-18
First Post: 2022-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
Sponsor: City of Hope Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-Cell Non-Hodgkin Lymphoma View
None Diffuse Large B-Cell Lymphoma View
None Mantle Cell Lymphoma View
None Recurrent B-Cell Non-Hodgkin Lymphoma View
None Recurrent Diffuse Large B-Cell Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Recurrent Transformed Non-Hodgkin Lymphoma View
None Transformed Non-Hodgkin Lymphoma View
Keywords: